- Global Pharma News & Resources

At 18.1% CAGR, Next Generation Sequencing Market is Anticipated to reach USD 21.3 Billion by 2025 | Analysis by Current Trends, Statistics Growth, Covid-19 Impact | Coherent Market Insights

The “Next Generation Sequencing Market” report provides a quick description about market status, size, companies share, growth, opportunities and upcoming trends. This report includes the corporate profile, values that the challenges and drivers & restraints that have a serious impact on the industry analysis. The information within the report that help form the longer term projections during the forecast year. The up so far analysis to assists in understanding of the changing competitive analysis. Additionally, the market strategies including moderate growth during the years.

The research on Next Generation Sequencing market scenario which will affect the overview the forecast period, including as opportunities, prime challenges, and current/future trends. To supply an in-depth analysis of all Next Generation Sequencing regions included within the report into sections to supply a comprehensive competitive analysis.

Get Your Sample Copy of the Next Generation Sequencing Market Report 2021

Some of the leading manufacturers and suppliers of the Next Generation Sequencing market are Thermo Fisher Scientific Inc., Agilent Technologies, Inc., BioMerieux S.A., F. Hoffmann-La Roche Ltd, Qiagen N.V., Illumina, Inc., Oxford Nanopore Technologies, and Beijing Genomics Co. Ltd.

The next-generation sequencing effort currently being executed across numerous research laboratories focuses on whole-genome sequencing with applications in diagnosing disease and assisting in treatments. Next-generation sequencing produces high-quality, sensitive, archival-accurate results in a timely manner thus enabling the researchers to conduct and compare genetic analysis. Mapping of the genetic basis of complex traits such as eye and lung disease, metabolic syndrome, and complex diseases like Alzheimer’s and Huntington’s disease will greatly benefit from next-generation sequencing. Some of the most exciting developments in next generation sequencing technology are Affinity+ and eRAXnext genomics systems that use Affinity chemistry to sequentially register and tag DNA fragments for automated tracking and analysis. Additionally, they use Affinity chemistry with Ingenuity Smart probes for multiplexed DNA analysis and tracking.

From the regional point of view, North America is expected to lead the global next-generation sequencing market owing to the increasing focus of key players to introduce novel next-generation sequencing products in the market. For instance, in May 2021, Bio-Rad Laboratories, Inc. a global leader of life science research and clinical diagnostic products, today announced the launch of the SEQuoia RiboDepletion Kit, which improves assay efficiency by eliminating irrelevant ribosomal RNA (rRNA) fragments from an RNA-Seq library

What Next Generation Sequencing Market Research Report Covers?

• This report covers definition, development, market status, geographical analysis of Next Generation Sequencing market.

• Competitor analysis including all the key parameters of Next Generation Sequencing market

• Market estimates for at least 7 years

• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and proposals)

• Strategic proposals in key business portions dependent available estimations

• Company profiling with point by point systems, financials, and ongoing improvements

• Mapping of the most recent innovative headways and Supply chain patterns

Buy This Complete A Business Report With Flat US $2000 Off @

The growing need for early detection of cancer and infectious diseases is propelling growth of the next-generation sequencing market. According to the World Health Organization, approximately 13% of cancers diagnosed in 2018 globally were attributed to carcinogenic infections, including Helicobacter pylori, human papillomavirus (HPV), hepatitis B virus, hepatitis C virus, and Epstein-Barr virus. According to The Burden of Cancer Worldwide, in 2018, there were 18.1 million new cases and 9.5 million cancer-related deaths worldwide. By 2040, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Moreover, the growing demand for DNA testing due to rapid advancements in whole-genome and exome sequencing procedures is further expected to augment the growth of the next-generation sequencing market.

In February 2021, QIAGEN and INOVIO Pharmaceuticals announced an extension of their partnership with a new master collaboration agreement to develop liquid biopsy-based companion* diagnostic products based on next-generation sequencing (NGS) technology to complement INOVIO’s therapies

In August 2020, Ancestry launches a next-generation sequencing product. The new product aims to help customers gain insights into their health and risk factors.

Ask for PDF sample copy of the Next Generation Sequencing market report

Main points in Next Generation Sequencing Market Report Table of Content

Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.5 Global Next Generation Sequencing Market Size Analysis from 2021 to 2027

11.6 COVID-19 Outbreak: Next Generation Sequencing Industry Impact

Chapter 2 Global Next Generation Sequencing Competition by Types, Applications, and Top Regions and Countries

2.1 Global Next Generation Sequencing (Volume and Value) by Type

2.3 Global Next Generation Sequencing (Volume and Value) by Regions

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.2 Regional Production Market Analysis

Chapter 4 Global Next Generation Sequencing Sales, Consumption, Export, Import by Regions (2016-2021)

Chapter 5 North America Next Generation Sequencing Market Analysis

Chapter 6 East Asia Next Generation Sequencing Market Analysis

Chapter 7 Europe Next Generation Sequencing Market Analysis

Chapter 8 South Asia Next Generation Sequencing Market Analysis

Chapter 9 Southeast Asia Next Generation Sequencing Market Analysis

Chapter 10 Middle East Next Generation Sequencing Market Analysis

Chapter 11 Africa Next Generation Sequencing Market Analysis

Chapter 12 Oceania Next Generation Sequencing Market Analysis

Chapter 13 South America Next Generation Sequencing Market Analysis

Chapter 14 Company Profiles and Key Figures in Next Generation Sequencing Business

Chapter 15 Global Next Generation Sequencing Market Forecast (2021-2027)

Chapter 16 Conclusions

View Press Release For More Information

Related Reports:


About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 16-Aug-2021